CHRS

Coherus BioSciences Inc. is an innovative biopharmaceutical company focused on developing and commercializing biosimilars and cutting-edge immuno-oncology therapies, primarily in the U.S. market. Headquartered in Redwood City, California, Coherus is dedicated to expanding patient access to high-quality biologic therapies while effectively lowering healthcare expenses. With a strong product pipeline and strategic partnerships, the company is well-positioned to meet the increasing demand for cost-effective treatment solutions in oncology and autoimmune diseases, making it an attractive investment opportunity in the rapidly evolving biotech landscape.